IPHA
Price
$2.03
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
193.36M
52 days until earnings call
VALN
Price
$7.68
Change
+$0.09 (+1.19%)
Updated
Jul 25 closing price
Capitalization
666.33M
16 days until earnings call
Interact to see
Advertisement

IPHA vs VALN

Header iconIPHA vs VALN Comparison
Open Charts IPHA vs VALNBanner chart's image
Innate Pharma SA
Price$2.03
Change-$0.00 (-0.00%)
Volume$3.49K
Capitalization193.36M
Valneva SE
Price$7.68
Change+$0.09 (+1.19%)
Volume$101.45K
Capitalization666.33M
IPHA vs VALN Comparison Chart in %
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. VALN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a Hold and VALN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IPHA: $2.03 vs. VALN: $7.68)
Brand notoriety: IPHA and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 37% vs. VALN: 210%
Market capitalization -- IPHA: $193.36M vs. VALN: $666.33M
IPHA [@Biotechnology] is valued at $193.36M. VALN’s [@Biotechnology] market capitalization is $666.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 0 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • IPHA’s FA Score: 0 green, 5 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, both IPHA and VALN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 5 TA indicator(s) are bullish while VALN’s TA Score has 6 bullish TA indicator(s).

  • IPHA’s TA Score: 5 bullish, 4 bearish.
  • VALN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VALN is a better buy in the short-term than IPHA.

Price Growth

IPHA (@Biotechnology) experienced а +5.73% price change this week, while VALN (@Biotechnology) price change was +17.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

IPHA is expected to report earnings on Sep 17, 2025.

VALN is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VALN($666M) has a higher market cap than IPHA($193M). VALN YTD gains are higher at: 75.663 vs. IPHA (10.326).
IPHAVALNIPHA / VALN
Capitalization193M666M29%
EBITDAN/A-55.24M-
Gain YTD10.32675.66314%
P/E RatioN/AN/A-
RevenueN/A186M-
Total CashN/A153M-
Total DebtN/A211M-
TECHNICAL ANALYSIS
Technical Analysis
IPHAVALN
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPOAY21.780.15
+0.69%
Epiroc Aktiebolag
BRBOF10.30N/A
N/A
BREMBO N V
HDIUF22.63N/A
N/A
ADENTRA Inc.
SVBT44.00N/A
N/A
SVB&T Corporation
LKST4.26N/A
N/A
LookSmart Group, Inc.

IPHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHA
1D Price
Change %
IPHA100%
-0.23%
MDGL - IPHA
43%
Loosely correlated
-0.26%
SLNO - IPHA
34%
Loosely correlated
-1.77%
VALN - IPHA
30%
Poorly correlated
+4.99%
QSI - IPHA
28%
Poorly correlated
-2.53%
VKTX - IPHA
27%
Poorly correlated
+2.75%
More

VALN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VALN has been loosely correlated with INRLF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VALN jumps, then INRLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VALN
1D Price
Change %
VALN100%
+4.99%
INRLF - VALN
42%
Loosely correlated
N/A
BMRN - VALN
36%
Loosely correlated
-1.26%
IMTX - VALN
33%
Poorly correlated
+1.71%
PTCT - VALN
32%
Poorly correlated
-3.41%
IPHA - VALN
32%
Poorly correlated
-0.23%
More